In 2024, Spanish pharma focused on stabilizing finances rather than expanding, with six major players seeing an 18% profit drop compared to 2023. While Faes Farma...
Spanish pharmaceutical companies had mixed results: Almirall and Reig Jofre shares dropped by 4% and 2.5%, respectively, while Faes Farma and PharmaMar saw increases of around...
Spanish pharma companies started the year maintaining the red of the previous year. In Q1, the aggregate capitalization registered a drop of 10.57%, with values such...